Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya
NCT ID: NCT07315295
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
68 participants
INTERVENTIONAL
2025-12-23
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Lactoferrin and Dosing Regimen on Iron Absorption From a Maize-based Porridge in Kenyan Infants
NCT03617575
Effect of Timing of Micronutrient Powder Consumption on Iron Absorption in Infants
NCT02989311
Iron and Prebiotics Fortification in Kenyan Infants
NCT02118402
The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency
NCT06816524
Evaluation of the Effects of Routine Iron Supplementation in Children on Gastrointestinal Iron Losses
NCT04721964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy children
Healthy children
Iron absorption from RUTF on Day 0
RUFT with 57Fe
Children with MAM/SAM
children with moderate or severe acute malnutrition
Iron absorption from RUTF on Day 0
RUFT with 57Fe
Treatment with RUTF for 80 days
Daily RUTF intake
Iron absorption from RUTF on Day 20
RUFT with 57Fe
Iron absorption from RUTF on Day 40
RUFT with 57Fe
Iron absorption from RUTF on Day 60
RUFT with 57Fe
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron absorption from RUTF on Day 0
RUFT with 57Fe
Treatment with RUTF for 80 days
Daily RUTF intake
Iron absorption from RUTF on Day 20
RUFT with 57Fe
Iron absorption from RUTF on Day 40
RUFT with 57Fe
Iron absorption from RUTF on Day 60
RUFT with 57Fe
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe acute malnutrition (SAM): WHZ \< -3.0
* moderate acute malnutrition (MAM): WHZ \< -2.0 a
* treated as outpatients (no acute medical conditions and a positive appetite test)
healthy children:
\- healthy: HAZ, WAZ and WHZ = 0
Exclusion Criteria
* Presence of acute medical conditions requiring inpatient management
12 Months
54 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETH Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicole Stoffel
Assistantprofessor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ETH/Oxford/JKUAT research facility
Msambweni, Kwale County, Kenya
ETH Zurich, Laboratory of Clinical Biopharmacy, Zurich, 8092
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAMI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.